Companion Animal Arthritis Market Size & Growth Forecast 2027–2036, By Segments (Indication, Animal Type, Treatment, Distribution Channel), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Companion Animal Arthritis Market size was worth USD 3.85 billion in 2026 and is expected to grow at a 6.6% CAGR between 2027 and 2036, attaining USD 7.3 billion by 2036. The industry revenue for 2027 is assessed at USD 4.06 billion.
Get more details on this report
Request Free Sample ReportCompanion Animal Arthritis Market Intelligence Snapshot
Regional Market Dynamics
- North America accounted for 37.10% of the market in 2026, supported by high pet ownership, established veterinary networks, routine diagnosis, and consistent adoption of long-term arthritis therapies.
- Asia Pacific is forecast to grow at a 7.91% CAGR as awareness of companion animal health rises, veterinary access improves, and more owners seek diagnosis and ongoing treatment for arthritis.
Segment Momentum
- Osteoarthritis accounted for 72% of the market in 2026 because it is the most commonly treated arthritis condition, requiring ongoing pain management, mobility support, and repeated veterinary care.
- Cats are the fastest-growing segment as improved recognition of feline arthritis leads to more diagnoses and treatment of previously undermanaged mobility and pain conditions.
Market Expansion Drivers
- Growing companion animal population increasing prevalence of osteoarthritis and joint disorders.
- Rising pet insurance penetration and veterinary spending supporting advanced arthritis treatments.
- Expanding use of biologics and long-acting pain therapies improving animal mobility outcomes.
Leading Market Participants
- Prominent companies in the companion animal arthritis market include Zoetis Inc. (United States), Elanco Animal Health Incorporated (United States), Boehringer Ingelheim International GmbH (Germany), Virbac S.A. (France), Ceva Santé Animale S.A. (France), Dechra Pharmaceuticals PLC (United Kingdom), Vetoquinol S.A. (France), Norbrook Laboratories Limited (United Kingdom), Eltech K-Laser S.r.l. (Italy).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 3.85 billion
- 2027 Estimated Market Size: USD 4.06 billion.
- Projected Market Size: USD 7.3 billion by 2036
- Growth Forecast: 6.6% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Osteoarthritis (Indication) | Dogs (Animal Type) | Medication (Treatment) | Veterinary Hospitals & Clinics (Distribution Channel)
- Emerging Opportunity Segment: Osteoarthritis (Indication) | Cats (Animal Type) | Supplements (Treatment) | Online Stores (Distribution Channel)
Market Growth Drivers and Industry Trends
Growing companion animal population increasing prevalence of osteoarthritis and joint disorders
A growing companion animal population will drive the companion animal arthritis market as a larger number of pets require veterinary attention for osteoarthritis and other joint-related disorders. Increasing recognition of mobility limitations among aging and affected animals is encouraging owners to seek professional diagnosis and treatment. This expands demand for therapeutic approaches aimed at managing pain, maintaining movement, and supporting everyday quality of life.
Rising pet insurance penetration and veterinary spending supporting advanced arthritis treatments
Higher pet insurance penetration and increasing willingness to spend on veterinary care will propel the companion animal arthritis market by improving access to more advanced treatment options. Insurance coverage can reduce financial barriers associated with ongoing arthritis management, while greater veterinary spending enables owners to pursue specialized therapies rather than relying solely on basic supportive care. These changes support broader utilization of clinical treatments for chronic joint conditions.
Expanding use of biologics and long-acting pain therapies improving animal mobility outcomes
Greater use of biologics and long-acting pain therapies is strengthening the companion animal arthritis market by providing veterinarians with additional options for managing chronic joint discomfort and impaired mobility. These therapies can support sustained symptom management and reduce the need for frequent treatment interventions, making arthritis care more practical for pet owners and helping animals maintain greater mobility during ongoing disease management.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Increasing prevalence of arthritis in companion animals | 2.50% | Short term (≤ 2 yrs) | North America, Europe | Medium | Fast |
| Rising pet ownership and healthcare spending | 2.00% | Medium term (2–5 yrs) | Asia Pacific, North America | Low | Moderate |
| Launch of innovative treatment options | 2.50% | Long term (5+ yrs) | Europe, North America (spillover: Asia Pacific) | Medium | Slow |
| Growing companion animal population increasing prevalence of osteoarthritis and joint disorders | 2.00% | Low | North America, Europe | High | Near Term |
| Rising pet insurance penetration and veterinary spending supporting advanced arthritis treatments | 1.60% | Low | North America, Asia Pacific | High | Mid Term |
| Expanding use of biologics and long-acting pain therapies improving animal mobility outcomes | 1.30% | Low | Europe, North America | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America led the companion animal arthritis market with a 37.10% share in 2026, reflecting high pet ownership, strong spending on veterinary care, and growing recognition of mobility and age-related conditions in companion animals. Pet owners are increasingly treating animals as family members and are more willing to pursue specialized diagnosis, long-term management, and supportive therapies for chronic conditions. Greater access to veterinary services and advanced diagnostic capabilities is helping identify arthritis at earlier stages, while growing awareness of pain management and animal quality of life is encouraging ongoing treatment. The expansion of preventive veterinary care and demand for specialized pet health products further reinforce the region's strong market position.
Asia Pacific (Fastest-Growing Region)
Asia Pacific represents the fastest-growing regional market as pet ownership increases and attitudes toward companion animal healthcare become more sophisticated. Rising urban pet populations and changing household lifestyles are contributing to greater demand for veterinary services and products focused on long-term animal wellness. Increasing awareness of chronic conditions, including mobility-related disorders, is encouraging pet owners to seek professional diagnosis and treatment rather than relying solely on basic care. Improvements in veterinary infrastructure and broader access to specialized animal healthcare are also supporting market development. As disposable incomes and willingness to spend on companion animal health improve across key markets, demand for arthritis management solutions is expected to broaden further.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Preventive Mobility ManagementGermany emphasizes early diagnosis and preventive care for companion animal arthritis, supported by strong veterinary engagement and pet wellness trends. Pet owners in Germany increasingly seek long-term management options that combine pain control with mobility-support therapies.
France 🇫🇷
Integrated Pet Wellness ApproachFrance is witnessing increasing attention to chronic joint conditions in companion animals, encouraging broader adoption of comprehensive arthritis management strategies. Veterinary practices in France are promoting combinations of medication, nutritional support, and mobility-enhancing therapies.
Italy 🇮🇹
Companion Care ModernizationItaly's expanding pet care sector is driving greater recognition of arthritis in aging dogs and cats. Veterinary providers in Italy are increasingly incorporating long-term pain management and supportive therapies to address mobility concerns and improve pet wellbeing.
Japan 🇯🇵
Senior Pet Health FocusJapan's aging pet population is creating sustained demand for arthritis management products and veterinary services. Clinics in Japan are expanding treatment offerings that include nutritional interventions and advanced therapeutics designed to support mobility and comfort in older companion animals.
South Korea 🇰🇷
Premium Veterinary ExpansionSouth Korea is experiencing growing demand for specialized pet healthcare services, including treatment for chronic musculoskeletal conditions. Pet owners in South Korea increasingly adopt premium arthritis therapies and rehabilitation solutions as companion animal care becomes more sophisticated.
United States 🇺🇸
Advanced Pet Care AdoptionThe U.S. companion animal arthritis market benefits from high veterinary spending and growing awareness of age-related mobility disorders in pets. Demand is increasing for multimodal treatment approaches, including pharmaceuticals, supplements, and regenerative therapies that improve long-term quality of life.
Segment Leadership and Growth Trends
Companion Animal Arthritis Market Share (%), by Indication, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportIndication Segment Analysis: Osteoarthritis (Largest & Fastest-Growing Segment)
Osteoarthritis dominated the companion animal arthritis market, accounting for a 72% share in 2026, while also representing the fastest-growing indication. Its strong position is supported by the high prevalence of degenerative joint conditions among companion animals and the resulting need for effective long-term management of pain, mobility limitations, and joint deterioration. Growing recognition of arthritis as a chronic condition requiring sustained veterinary care is encouraging greater adoption of therapeutic and supportive treatment options. Increasing attention to animal mobility and quality of life is further strengthening demand for osteoarthritis-focused interventions, reinforcing the segment's leading and growth position.
Animal Type Segment Analysis: Dogs (Largest Segment) vs Cats (Fastest-Growing Segment)
The dogs segment held the largest share of the companion animal arthritis market at 63% in 2026. Its dominance is supported by the widespread occurrence of joint degeneration and mobility-related conditions in dogs, particularly as owners increasingly seek veterinary intervention to preserve mobility and quality of life. Greater awareness of arthritis symptoms and the availability of therapeutic approaches are encouraging earlier diagnosis and ongoing disease management, sustaining demand for arthritis treatments in canine populations.
Cats represent the fastest-growing animal type segment, supported by increasing recognition of arthritis and mobility impairment in feline populations. Arthritis in cats can be less apparent because affected animals often conceal discomfort or show subtle behavioral changes, creating a growing need for improved awareness and veterinary assessment. As owners and veterinarians become more attentive to mobility, activity, and pain-related changes in cats, demand for appropriate arthritis management is expanding.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Indication | Osteoarthritis, Others | Osteoarthritis | Osteoarthritis |
| Animal Type | Dogs, Cats, Others | Dogs | Cats |
| Treatment | Medication, Supplements, Others | Medication | Supplements |
| Distribution Channel | Veterinary Hospitals & Clinics, Retail Pharmacies, Online Stores, Others | Veterinary Hospitals & Clinics | Online Stores |
Competitive Landscape and Market Positioning
Prominent players in the companion animal arthritis market:
1. Zoetis Inc. (United States)
2. Elanco Animal Health Incorporated (United States)
3. Boehringer Ingelheim International GmbH (Germany)
4. Virbac S.A. (France)
5. Ceva Santé Animale S.A. (France)
6. Dechra Pharmaceuticals PLC (United Kingdom)
7. Vetoquinol S.A. (France)
8. Norbrook Laboratories Limited (United Kingdom)
9. Eltech K-Laser S.r.l. (Italy)
The companion animal arthritis market is expanding due to increasing focus on pet mobility and chronic care solutions. Therapeutic innovation is improving pain management and joint health support. The companion animal arthritis market is also witnessing development of long-acting treatment formulations. Growth is driven by rising pet healthcare awareness.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Zoetis Inc. (United States) | |||||||
| Elanco Animal Health Incorporated (United States) | |||||||
| Boehringer Ingelheim International GmbH (Germany) | |||||||
| Virbac S.A. (France) | |||||||
| Ceva Santé Animale S.A. (France) | |||||||
| Dechra Pharmaceuticals PLC (United Kingdom) | |||||||
| Vetoquinol S.A. (France) | |||||||
| Norbrook Laboratories Limited (United Kingdom) | |||||||
| Eltech K-Laser S.r.l. (Italy). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Zoetis | Jun-23 | Zoetis launched a monoclonal antibody therapy for canine osteoarthritis targeting nerve growth factor to provide long-lasting pain relief in dogs. The introduction expands Zoetis’s biologics portfolio in companion animal pain management and reinforces its leadership in advanced therapeutic solutions for veterinary osteoarthritis care. |
| Elanco | Apr-22 | Elanco partnered with Ginkgo Bioworks to establish BiomEdit, a veterinary-focused company developing engineered microbes and probiotics for animal health applications. The initiative supports innovation in biologics and microbiome-based therapies, expanding Elanco’s capabilities in next-generation veterinary treatment solutions relevant to chronic conditions such as arthritis. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Companion Animal Arthritis Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Disease Severity | Mild, Moderate, Severe |
| Route of Administration | Oral, Injectable, Topical |
| Prescription Status | Prescription Products, Non-Prescription Products |
Companion Animal Arthritis Market — Custom
| Custom Chapter | Custom Details |
|---|---|
| Pet Healthcare Spending Trend Analysis |
|
| Pet Owner Treatment Preference Analysis |
|
| Emerging Therapeutic Innovation Outlook |
|
Need a different cut of the data?
Request Custom ResearchWhat is the market size of companion animal arthritis?
What is the anticipated CAGR of the companion animal arthritis industry?
How is the growing companion animal population influencing osteoarthritis treatment demand in the companion animal arthritis market?
How are pet insurance and advanced therapies shaping treatment adoption in the companion animal arthritis market?
Why does osteoarthritis dominate the companion animal arthritis market?
Why are cats the fastest-growing animal type in the companion animal arthritis market?
Why is North America the largest regional market for companion animal arthritis treatments?
What factors are accelerating market growth in Asia Pacific?
Which organizations are considered leaders in the companion animal arthritis landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization